Why AstraZeneca’s COVID-19 Vaccine Is Being Suspended

It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal.

It’s…

Read more

Fear of Fentanyl is Driving Laws That Could Lead to Overdoses

Since the U.S. drug war was declared in 1971, various drugs have been identified as public enemy number one—from crack cocaine, in the 1980s, to prescription opioids in the early 2000s. Today, the primary villain is fentanyl, a synthetic opioid about 50 times more potent than heroin. In 2021, more than 71,000 people in the U.S. died after overdoses involving synthetic opioids—mostly…

Read more

Why, When and How to Test At-Home for COVID-19

As we close in on two years of living with COVID-19, quick and accurate tests for COVID-19 remain an urgent priority. In fact, as schools reopen, businesses resume operations and people return to work, rapid testing could be the key to preventing Delta or any new variants of SARS-CoV-2 from flaring into even larger outbreaks.

But that’s only if testing is used in the right way, at t…

Read more

Why Chuck Yeager Claimed He Had No ‘Right Stuff’

Frank Borman did not expect to hear a congratulations from Chuck Yeager one day in 1962—and that’s just as well because he didn’t get one. It wasn’t a surprise that Yeager wouldn’t extend much courtesy to the likes of Borman. There were rules, after all, and there was a hierarchy after all, and Yeager, who on Dec. 7 died at the age of 97, was then the commander of …

Read more

Why Europe’s New Climate Rules Matter to American Companies

(To get this story in your inbox, subscribe to the TIME CO2 Leadership Report newsletter here.)

The E.U. is in the middle of implementing its Green Deal program with a wide range of implications for how the world tackles climate change. Perhaps nothing is of more obvious import to global business leaders than the bloc’s coming climate disclosure rules, which are scheduled t…

Read more

Why ESG Is So Confusing

(To get this story in your inbox, subscribe to the TIME CO2 Leadership Report newsletter here.)

A few weeks ago, I wrote a story about the anti-ESG movement in Texas’s foray into insurance. Soon after, I received a very thoughtful response from a declared ESG opponent taking issue with the idea that ESG metrics are relevant for insurers. The one issue: he had used the term …

Read more